Related Experiment Video
Updated: Aug 10, 2026

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
Published on: April 7, 2015
Chlamydia pneumoniae IgG and the severity of coronary atherosclerosis
Insights
Higher Chlamydia pneumoniae IgG antibody levels correlate with more severe coronary atherosclerosis in patients with stable angina. This suggests a potential link between this infection and heart disease progression.
Area of Science:
- Cardiology
- Infectious Diseases
- Immunology
Background:
- Coronary atherosclerosis is a leading cause of cardiovascular disease.
- Chlamydia pneumoniae infection has been implicated in cardiovascular pathology.
- Investigating the link between C. pneumoniae IgG and atherosclerosis severity is crucial.
Purpose of the Study:
- To compare Chlamydia pneumoniae IgG antibody levels with the extent of coronary atherosclerosis.
- To determine if higher C. pneumoniae IgG levels are associated with more severe coronary artery disease.
Main Methods:
- Studied 92 patients with stable angina undergoing coronary angiography.
- Measured C. pneumoniae IgG antibody levels before angiography.
- Quantified the number of coronary arteries with >=50% stenosis.
- Grouped patients based on C. pneumoniae IgG levels (above or below 46 EIU/L).
Main Results:
- Patients with higher C. pneumoniae IgG levels exhibited more severe coronary atherosclerosis.
- The average number of diseased arteries was significantly higher in the high IgG group (2.1) compared to the low IgG group (1.4) (p<0.0001).
Conclusions:
- Elevated Chlamydia pneumoniae IgG antibody titers are associated with a greater degree of coronary atherosclerosis.
- The findings suggest a potential causative relationship between C. pneumoniae infection and coronary atherosclerosis severity.
- Further research is needed to definitively establish causality.
Abstract:
BACKGROUND: The aim of this study was to compare Chlamydia pneumoniae IgG and the extent of coronary atherosclerosis. METHODS: We investigated 92 patients with stable angina pectoris who underwent coronary angiography to assess chest pain. Before angiography, C. pneumoniae IgG was analyzed. The number of major coronary arteries (1-3) having at least one diameter narrowing (>/=50%) stenosis was determined. The patients were divided into two groups of equal size, according to C. pneumoniae IgG levels. One group included individuals with C. pneumoniae IgG levels exceeding 46 enzyme-immuno-units (EIU)/L and the other consisted of subjects with IgG concentrations below 46 EIU/L. RESULTS: Subjects with higher antibody concentrations had a more severe disease. The number of diseased arteries was 2.1+/-0.8 (S.D.) and 1.4+/-0.6 (S.D.) for the two groups, respectively. The difference is highly significant (p<0.0001). CONCLUSIONS: This study suggests a causative relationship between C. pneumoniae IgG and the degree of coronary atherosclerosis. It does not, however, prove causality.
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atypical Pneumonia
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

